Via Agathe Quignot
|
|
Rescooped by
Lionel Reichardt / le Pharmageek
from Digital et santé
September 23, 2012 3:42 AM
|
Une veille sur la santé numérique en France et à l’international : politiques publiques, données, infrastructures, IA, services et usages. Études, rapports et retours de terrain sélectionnés par Lionel Reichardt, Pharmageek, pour comprendre les transformations et éclairer les décisions.
Your new post is loading...
Your new post is loading...
Haute Autorité de Santé.9 likes · 0 talking about this (“@SylRP: La nouvelle page FB de la #HAS, c'est début de la qualité 2.0 :) http://t.co/soHKlHF6 #santé #health20fr”...)...
Via Agathe Quignot No comment yet.
Sign up to comment
Learn why 'wait and see' isn't such a good idea. Via Gilles Jourquin, Pharmacomptoir / Corinne Thuderoz
Marty Note Via Martin (Marty) Smith, Brian Yanish - MarketingHits.com
Premiers résultats du P4P : la CNAM salue une « dynamique ...Le Quotidien du MédecinL'assurance-maladie a présenté jeudi en commission paritaire nationale (CPN) les résultats du premier semestre 2012 des médecins généralistes sur le respect des principaux...
La recherche de traitements contre les maladies rares apparaît comme un des axes majeurs de développement des industriels du médicament.
Médiamétrie vient d'annoncer qu'il reportait d'un mois la première publication de la mesure hybride en France.
NEW YORK–(BUSINESS WIRE)–U.S. consumers seeking health information online are more likely to visit Wikipedia than health magazine websites or Facebook, connect through a PC rather than a mobile device, and be ...
Via Tracy Parish
Curiouscatherine shares:
Office of National Statistics on internet use
Oxford Internet Institute audit of online behaviours http://microsites.oii.ox.ac.uk/oxis/
CLG report on Digital Inclusion http://www.communities.gov.uk/publications/communities/digitalinclusionanalysis
A presentation by herself on digital inclusion http://prezi.com/45c1xsm6o-6d/digital-inclusion/?auth_key=caa41a92407607646144e9a598ccdfbba426bffc
Spirometers are commonly used devices that help physicians diagnose and track the progress of various lung conditions. Patients are even using the de...
Via uri goren
BRIC Digital Physician Study: Physician Digital Behaviors Unique Across ...The Herald | HeraldOnline.comManhattan Research, a Decision Resources Group company, conducts annual research studies covering digital health trends among healthcare... Via Gilles Jourquin, Jean-François Gouhier
Is the placebo effect something that demands the presence of a living human - or can we program it into an app? What happens to healthcare if we can? (#health #ff #us Can digital medicine have a placebo effect? Via Gilles Jourquin, Philippe Marchal
The latest mHealth project by the government of India looks to strike at the alleged root of costly medical care : the widely variable costs of branded drugs. The Indian government has taken the initiative to use simple messaging services (SMS) to educate the public on drug prices. Via Philippe Marchal
|
With e-detailing, availing details about different pharmaceutical products becomes extremely easy and convenient. Today, more and more countries in the world are opting for this technology.
Via Nikos Papaioannou
Tiffany Peterson (@TiffanyAndLupus), empowered Lupus patient, in interview with pharmaphorum (@pharmaphorum) as part of their patient perspectives series observes:
'[Pharma needs to serve] the strong need for vital information and / or webinars, programs and support groups [among patients]. It’s really important for this content to be online because Lupus is a disease that can be really debilitating for the people living with it. So many patients can’t physically come to informational seminars, programs and support groups but they can log in from their computers. A lot of these programmes would help assist them with daily coping and positive living.
Pharma could also help assist by funding unbiased programming and informational seminars to increase patients literacy on their illness and it also would be nice to know what future drugs are in development.
A huge deficit in pharma is the lack of patient involvement. I speak to so many patient advocates that have these amazing ideas and it’s always great to crowd source ideas whenever you’re facing an issue. You never know what can come out of it. There’s no reason for pharma to fear patient engagement. For most engaged patient thought leaders there are no hidden agenda, we truly wish to provide better outcomes for overall patient safety. Our bottom line is saving patient lives.'
Tracking your body with technologyCNNAs of Thursday, there were 873 people registered for the Quantified Self message boards, where people discuss the latest apps and research.
Le magazine Science vient de publier son classement 2012 des meilleurs employeurs des industries biopharmaceutique, pharmaceutique, et biotechnologique. Cette année, Regeneron (Tarrytown, NY) arrive à la 1ère place ...
Alors que la France souffre d'une désindustralisation croissante, les Entreprises du Médicament, secteur de haute technologie, demeurent largement implantées sur le territoire français avec 224 sites industriels représentant plus de 40 000 emplois...
Boursier.comMaladies rares : un des axes majeurs de développement des ...Boursier.comAinsi, selon le dernier rapport d'Orphanet, plus de 70 entreprises du médicament sont impliquées dans la mise au point de médicaments désignés comme orphelins ou...
Avec près de 120 000 e-marchands en France, l'offre de produits est plus que jamais pléthorique sur Internet. L'enjeu pour le consommateur : faire le bon choix. Dans cette optique, les avis et re... Via Nathalie LAMRI
In this randomized study, physicians reported that they would be less willing to prescribe drugs tested in low-rigor trials than those tested in medium-rigor trials, and would be more willing to prescribe... Via Gilles Jourquin, Philippe Marchal
Sites like Novo Nordisks Cornerstones4Care are bringing fullspectrum segmentation to the task of bolstering adherence and being there for the patient...
Via Philippe Marchal
memo: Understanding consumers’ multichannel choices across the different stages of the buying ...
Via orlaw |
Your new post is loading...